James F. Cummings
Vaxart (United States)(US)
Publications by Year
Research Areas
Malaria Research and Control, Mosquito-borne diseases and control, Viral gastroenteritis research and epidemiology, vaccines and immunoinformatics approaches, Respiratory viral infections research
Most-Cited Works
- → Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans(2003)557 cited
- → Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection(2009)536 cited
- → Sarcocystis neurona n. sp. (Protozoa: Apicomplexa), the Etiologic Agent of Equine Protozoal Myeloencephalitis(1991)253 cited
- → Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A(2009)208 cited
- → Common and Divergent Immune Response Signaling Pathways Discovered in Peripheral Blood Mononuclear Cell Gene Expression Patterns in Presymptomatic and Clinically Apparent Malaria(2006)149 cited
- → Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area(2009)142 cited
- → DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity(2013)142 cited
- → A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression(2011)136 cited
- → Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy(2016)130 cited
- → Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research(2008)128 cited